Gene expression and protein purification. rpoA was expressed in E. coli BL21 (DE3) (Novagen, Madison, WI, USA) harboring the plasmid pIA287. Cells were grown in M9 minimal medium 3, 4 containing 100 µg/ml ampicillin at 37 °C. At an optical density of 600 nm (OD 600 ) of ~ 0. rpoC was expressed in E. coli Rosetta (DE3) pLysS (Novagen, Madison, WI, USA). The recombinant protein harbored a seven amino acid linker followed by a hexahistidine tag (His 6 ) at the C-terminus. Cells were grown in M9 minimal medium 3,4 containing 30 µg/ml kanamycin and 34 µg/ml chloramphenicol at 37 °C. When an OD 600 of ~ 0.5 was reached the temperature was lowered to 16 °C and gene expression was induced with 1 mM IPTG at an OD 600 of 0.6-0.8. Cells
were harvested 6 h after induction, resuspended and lysed as described above using buffer A (50 mM Tris/HCl (pH 7.5), 500 mM NaCl, 5 % (v/v) glycerol, 10 mM MgCl 2 , 10 µM ZnCl 2 , 10 mM imidazole). After centrifugation (30 min, 12,000 x g, 4 °C) the supernatant was applied to a HisTrap HP column (GE Healthcare, Munich, Germany). After washing with buffer A, elution was carried out using a step gradient with increasing imidazole concentrations (10-500 mM in buffer A).
Fractions containing β' were combined. Following dialysis against the required buffer the protein solution was concentrated by ultrafiltration (MWCO = 10 kDa) and stored at -80 °C after shock freezing in liquid nitrogen. One liter culture yielded 15 mg protein.
The ω subunit with N-terminal His 6 -SUMO tag was produced in E. coli Rosetta (DE3) pLysS harboring pET28M-SUMO1/rpoZ. Cells were grown in M9 minimal medium 3, 4 in the presence of 30 µg/ml kanamycin and 34 µg/ml chloramphenicol at 37 °C until an OD 600 of 0.4 was reached.
The temperature was lowered to 25 °C and at an OD 600 of 0.6-0.8 expression was induced with 1 mM IPTG. Cells were harvested after 4 h, resuspended and lysed as described above. In this case 25 mM Tris/HCl (pH 7.5), 300 mM NaCl, 10 mM imidazole was used for resuspension. After centrifugation (12,000 x g, 30 min, 4 °C), the supernatant was applied to a HisTrap HP column.
After washing with 25 mM Tris/HCl (pH 7.5), 300 mM NaCl, 10 mM imidazole, elution was performed using a step gradient with increasing imidazole concentrations (10-500 mM in resuspension buffer). Fractions containing His 6 -SUMO-ω were combined and cleaved during dialysis overnight against 25 mM Tris/HCl (pH 7.5), 300 mM NaCl by Senp2, a protease that cleaves directly after SUMO protein. The protein solution was reapplied to the HisTrap HP column.
Pure ω was found in the flow through, dialyzed against the required buffer, concentrated by ultrafiltration (MWCO = 3 kDa) and stored at -80 °C after freezing with liquid nitrogen with a yield of 3 mg protein per liter culture.
Tagless ω was used for in vitro assembly of RNAP and produced in E. coli Rosetta (DE3) pLysS containing pET32a/rpoZ. Cells were grown in M9 minimal medium 3,4 containing 100 µg/ml ampicillin and 34 µg/ml chloramphenicol at 37 °C. After induction with 0.1 mM IPTG at an OD 600 of 0.6-0.8 cells were grown for another 3 h before harvesting (9,000 x g, 15 min).
NusA-NTD contained amino acids 1-125 and was produced in E. coli BL21 Star (DE3) (Invitrogen, Darmstadt, Germany) harboring pET101_NusA-NTD. Cells were grown at 37 °C in LB medium containing ampicillin (100 µg/ml) until an OD 600 of 0.6 was reached. The gene of the SUMO protease SENP2 was expressed in E. coli Rosetta (DE3) (Novagen, Madison, WI, USA) harboring the plasmid pET28b-senp2. Cells were grown in LB medium containing 30 µg/ml kanamycin and 34 µg/ml chloramphenicol at 37 °C. At OD 600 ~ 0.7 expression was induced by 1 mM IPTG. Cells were harvested after 4 h (9,000 x g, 15 min, 4°C), resuspended in 40 mM Tris/HCl (pH 7.5) containing 500 mM NaCl, 10 mM imidazole and 5 mM DTT and disrupted by a microfluidizer. The supernatant was applied to a HisTrap HP column. Elution was performed using a step gradient with increasing imidazole concentrations (10-500 mM in resuspension buffer). The fractions containing SENP2 were combined, dialyzed against 5 mM
Tris/HCl (pH 7.5), 250 mM NaCl, 10 mM DTT, 0.1 mM EDTA and concentrated by ultrafiltration (MWCO = 10 kDa). Finally the glycerol concentration was adjusted to 20 %, aliquots were frozen in liquid nitrogen and stored at -80 °C.
The production and purification of NusB:NusE Δ , NusB, RNAP α-CTD, NusG-NTD, NusG-CTD and NusA-AR2 were carried out as described previously (Refs. [5] [6] [7] for NusB:NusE Δ and NusB, Ref. 8 for αCTD, Ref. 9 for NusG-NTD, Ref. 6 for NusG-CTD, Ref. 8 for NusA-AR2).
Formaldehyde crosslink. The crosslinking of RNAP and NusB:NusE Δ was based on the SPINE method 10 . 7.7 nmol RNAP were mixed with 15.4 nmol NusB:NusE ⊗ in 25 mM HEPES (pH 7.5), 100 mM NaCl and a 4 % (w/v) paraformaldehyde solution in the same buffer was added to a final concentration of 0.6 % (w/v). For the crosslink, the mixture was incubated at 37 °C for 20 min.
0.7 ml of Ni 2+ chelating sepharose (50 % (w/v), GE Healthcare, Munich, Germany), equilibrated with 25 mM HEPES (pH 7.5), 100 mM NaCl, were added and incubated for 20 min at room temperature. Afterwards the mixture was transferred to a 2.5 ml gravity flow column and the flow trough was collected. The column was washed ten times with 1 ml of 25 mM HEPES (pH 7.5),
